HighLife
TMVR development
HighLife has raised €124M across 3 funding rounds from 6 investors, most recently a round in Sep 2026. Based in Paris, France; active in Healthtech. Data as of 4 Nov 2026.
Total raised
€124M
€124,300,000
Funding rounds
3
Investors
6
distinct backers
Active since
2017-10
latest 2026-09
Funding by year
EUR raised per year · 2026 YTDHighLife — funding by year — interactive chart.
Data table
| HighLife — funding by year | |
|---|---|
| 2017 | €12M |
| 2018 | €32M |
| 2026 | €80M |
Signals
High confidenceRaise-next likelihood14
base rate 30% for Other
- ▼ Raised very recently
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood23
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 9y since founding (typical exit age)
- ▲ Recently backed by strong-exit-track investors
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds- 2026-09-22Other€80MAndera Partners,Mérieux Equity Partners,other investors,Sofinnova Partners+1 more
- 2019-01-01Series B€32M
- 2017-10-27Other€12M
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-09-22 | Other | €80M | Andera Partners,Mérieux Equity Partners,other investors,Sofinnova Partners,Supernova Invest | View deal → |
| 2019-01-01 | Series B | €32M | Andera Partners,Venture Partners | View deal → |
| 2017-10-27 | Other | €12M | Sofinnova Partners | View deal → |
Investors
6Related news
Similar companies
same sector, similar size- Tissium€160MFrance · Healthtech
- GenSight Biologics€87MFrance · Healthtech
- Uromems€126MFrance · Healthtech
- Bioserenity€107MFrance · Healthtech
- FineHeart€110MFrance · Healthtech
- Enterome€78MFrance · Healthtech
Global coverage: FundingData